T.Man Pharmaceutical PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	425.09	448.39	348.04	307.17	22.19	66.9
Cash & Short-Term Investments	425.09	448.39	348.04	307.17	22.19	66.9
Cash Growth	22.14%	28.83%	13.30%	1284.31%	-66.83%	-
Accounts Receivable	604.04	596.4	577.79	507.27	256.08	206.77
Other Receivables	27.44	17.53	38.75	21.37	23.94	8.08
Receivables	631.48	613.93	616.54	528.64	280.02	214.84
Inventory	513.58	541.45	481.82	357.96	308.9	410.68
Other Current Assets	451.47	470.32	4.99	32.2	4.21	7.25
Total Current Assets	2,022	2,074	1,451	1,226	615.32	699.66
Property, Plant & Equipment	1,137	1,143	1,048	930.41	742.63	724.85
Long-Term Investments	-	-	-	-	-	5
Other Intangible Assets	34.49	33.84	25.69	12.56	1.23	0.27
Long-Term Deferred Tax Assets	35.82	34.25	38.89	40.69	-	-
Other Long-Term Assets	283.87	170.23	63.18	68.24	199.02	171.13
Total Assets	3,513	3,456	2,627	2,278	1,558	1,601
Accounts Payable	350.34	370.1	331.91	333.08	192.3	120.03
Short-Term Debt	1,015	1,080	503.43	535	614.57	805.17
Current Portion of Long-Term Debt	-	-	33.08	22	16.01	48.34
Current Portion of Leases	5.13	5.66	7.08	4.55	3.01	0.64
Current Income Taxes Payable	51.71	27.53	22.63	110.2	11.34	4.65
Current Unearned Revenue	78.23	72.01	100.29	73.8	-	-
Other Current Liabilities	10.32	20.79	23.98	20.46	59.06	21.2
Total Current Liabilities	1,511	1,576	1,022	1,099	896.29	1,000
Long-Term Debt	-	-	-	33.08	8.33	24.36
Long-Term Leases	63.92	64.95	47.89	44.36	28.28	24.7
Other Long-Term Liabilities	0.75	0.58	2.39	26.93	25.89	14.86
Total Liabilities	1,621	1,686	1,108	1,236	987	1,086
Common Stock	300	300	246.43	187.3	187.3	50
Additional Paid-In Capital	1,394	1,394	305.88	305.88	305.88	-
Retained Earnings	449.73	327.82	993.46	575.48	103.91	98.34
Comprehensive Income & Other	-251.78	-251.78	-26.37	-26.37	-24.95	366.47
Total Common Equity	1,892	1,770	1,519	1,042	572.14	514.81
Minority Interest	-	-0	0	0	-0.93	-
Shareholders' Equity	1,892	1,770	1,519	1,042	571.21	514.81
Total Liabilities & Equity	3,513	3,456	2,627	2,278	1,558	1,601
Total Debt	1,084	1,151	591.48	638.99	670.21	903.21
Net Cash (Debt)	-658.96	-702.22	-243.44	-331.82	-648.02	-836.31
Net Cash Per Share	-1.82	-2.04	-0.88	-1.33	-8.98	-12.54
Filing Date Shares Outstanding	400	400	328.57	249.73	249.73	66.67
Total Common Shares Outstanding	400	400	328.57	249.73	249.73	66.67
Working Capital	510.88	497.98	428.98	126.89	-280.97	-300.37
Book Value Per Share	4.73	4.42	4.62	4.17	2.29	7.72
Tangible Book Value	1,857	1,736	1,494	1,030	570.91	514.54
Tangible Book Value Per Share	4.64	4.34	4.55	4.12	2.29	7.72
Land	-	124.07	108.09	94.16	64.95	64.95
Buildings	-	1,104	1,014	897.56	713.66	672.08
Machinery	-	609.53	548.56	448.73	415.39	378.1
Construction In Progress	-	81.94	68.6	93.44	82.16	75.3

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.